About this trial
Patients undergoing buccal urethroplasty will often have significant post-operative oral pain from the graft site. Various graft harvest techniques and methods for post-harvest hemostasis including graft site closure have been explored. Despite the frequency of this clinical scenario there is no established best practice for peri-operative pain management in this patient population. In addition to traditional post operative pain control, groups have sought various peri-operative anesthetic regimens to improve post operative pain. This has led recently to the description of various regional blocks including buccal and periorbital blocks for peri-operative local anesthetic. No study has looked at superiority of regional pain management in this patient population. This study will aim to assess three established anesthetic protocols for oral pain control in a blinded, randomized controlled trial.
Hypothesis: Patients who have buccal block will have lower post op pain without any increase adverse oral outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men, age 18 or older
Undergoing anterior urethroplasty with buccal grafting
Able to consent
Disqualifiers
Taking chronic opiates for pain
Diagnosis of chronic pain
Prior buccal urethroplasty
Vulnerable population (e.g. prisoner)
Trial design
Parallel
Treatments tested in this trial
Standard Buccal Harvest
DrugOur institutions current anesthetic regimen. Comparison group
Basic buccal procedure + Long acting local
DrugAddition of long-acting local anesthetic to the wound bed following the oral graft harvest.
Basic buccal procedure + Buccal block
DrugAddition of long-acting local anesthetic as a buccal block after oral graft harvest
Treatment groups
Trial outcomes
Primary outcomes
Change(s) in Post-operative pain
The Wong-Baker FACES pain scale is a validated scale where a score of 0 is no pain and 10 is the worst pain imaginable. Pain greater than or equal to 5 would result in significant limitations on daily life. Oral, incisional (surgical site), and overall pain will each be assigned a score of 0-10 at each time point (9 total scores).
Secondary outcomes
Change(s) in Post-operative Narcotic use
Patient measure of number of oxycodone tablets taken (0-5). Patient request for additional narcotic medicaiton (Yes/No) Patient measure of adherence to non-narcotic pain regiman (Yes/No)
Other outcomes
Peri-operative Complications
Clavien-Dingo is a validated tool to measure the severity of post-operative outcomes. Class I are mild and require no treatment. Class V is death.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, San Francisco
Lead sponsor
MedStar Georgetown University Hospital
Collaborator